Changchun BCHT Biotechnology Co. (SHA:688276)

SHA:688276 Revenue

Changchun BCHT Biotechnology Co. had revenue of 259.32M CNY in the quarter ending September 30, 2026, with 36.81% growth. This brings the company's total for the last twelve months to 694.47M, up 2.50% year-over-year. In the year 2025, Changchun BCHT Biotechnology Co. had annual revenue of 605.07M, down -50.77%. That makes Changchun BCHT Biotechnology Co. the 22,398th largest company in the world by revenue and 4,094th in China.

• Revenue (ttm): 694.47M
• Revenue Growth: +2.50%
• P/S Ratio: 9.30
• Revenue / Employee: 566.45K
• Employees: 1,226
• Market Cap: 6.39B

Revenue Chart

Chart

Chart

Revenue by Geography

Chart

• Eastern Region 247.02M 40.8%
• Southern Region 115.21M 19.0%
• Southwest 77.03M 12.7%
• Northwest 48.42M 8.0%
• Northeast 47.17M 7.8%
• Central China 46.82M 7.7%
• Foreign 15.46M 2.6%
• Northern Region 7.91M 1.3%

Fiscal year ended Dec 31, 2025 See the full SHA:688276 breakdown

Revenue History

Fiscal Year End	Revenue	Change	Growth
Dec 31, 2025	605.07M	-624.01M	-50.77%
Dec 31, 2024	1.23B	-595.60M	-32.64%
Dec 31, 2023	1.82B	753.24M	70.30%
Dec 31, 2022	1.07B	-130.58M	-10.86%
Dec 31, 2021	1.20B	-239.33M	-16.60%

Data Source: S&P Global Market Intelligence Last updated: Oct 29, 2026

Revenue data is provided by S&P Global Market Intelligence and updates within hours after each earnings release, which is every three months for this company.

Update frequency:

Quarterly

Last checked:

Nov 10, 2026

Data Sources Report a data error